Cite
HARVARD Citation
Levy, A. et al. (n.d.). Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial. Radiotherapy and oncology. 114 (3), pp. 415-416. [Online].